Group One Trading’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,924
Closed -$132K 7486
2022
Q3
$121K Buy
+14,924
New +$102K ﹤0.01% 4597
2021
Q4
Sell
-1,600
Closed -$11.9K 8380
2021
Q3
$15K Buy
+1,600
New +$12K ﹤0.01% 7315
2021
Q1
Sell
-317
Closed -$2.39K 7697
2020
Q4
$2K Buy
+317
New +$2.41K ﹤0.01% 6241

Other funds holding FENC

Group One Trading's FENC Position: Q4 2022 in Review

Group One Trading sold out of Fennec Pharmaceuticals (FENC) in Q4 2022, closing a stake of 14,924 shares — an estimated $132K sold.

Group One Trading first reported a position in FENC in Q4 2020 and held it in 3 quarters. The position peaked at $121K in Q3 2022. 43 funds tracked by Wall St. Rank hold FENC as of Q4 2022.

  • Group One Trading reported no remaining Fennec Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 14,924 Fennec Pharmaceuticals shares in Q4 2022, an estimated $132K.
  • Group One Trading first reported a position in Fennec Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Group One Trading's Fennec Pharmaceuticals position peaked at $121K in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.